Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons

Richard J. Konkol; Richard B. Mailman; Elizabeth G. Bendeich; A. Marcine Garrison; Robert A. Mueller; George R. Breese

doi:10.1016/0006-8993(78)90154-3

Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons

Richard J. Konkol, Richard B. Mailman, Elizabeth G. Bendeich, A. Marcine Garrison, Robert A. Mueller, George R. Breese

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Abstract

Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.

Original language	English (US)
Pages (from-to)	277-285
Number of pages	9
Journal	Brain research
Volume	144
Issue number	2
DOIs	https://doi.org/10.1016/0006-8993(78)90154-3
State	Published - Apr 14 1978

All Science Journal Classification (ASJC) codes

General Neuroscience
Molecular Biology
Clinical Neurology
Developmental Biology

Access to Document

10.1016/0006-8993(78)90154-3

Cite this

@article{48df1385644745f2b50d4b0c96bb0ff6,

title = "Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons",

abstract = "Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.",

author = "Konkol, {Richard J.} and Mailman, {Richard B.} and Bendeich, {Elizabeth G.} and Garrison, {A. Marcine} and Mueller, {Robert A.} and Breese, {George R.}",

year = "1978",

month = apr,

day = "14",

doi = "10.1016/0006-8993(78)90154-3",

language = "English (US)",

volume = "144",

pages = "277--285",

journal = "Brain research",

issn = "0006-8993",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons

AU - Konkol, Richard J.

AU - Mailman, Richard B.

AU - Bendeich, Elizabeth G.

AU - Garrison, A. Marcine

AU - Mueller, Robert A.

AU - Breese, George R.

PY - 1978/4/14

Y1 - 1978/4/14

N2 - Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.

AB - Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.

UR - http://www.scopus.com/inward/record.url?scp=0017836986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017836986&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(78)90154-3

DO - 10.1016/0006-8993(78)90154-3

M3 - Article

C2 - 638764

AN - SCOPUS:0017836986

SN - 0006-8993

VL - 144

SP - 277

EP - 285

JO - Brain research

JF - Brain research

IS - 2

ER -

Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this